Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

679
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
679
Drug Discovery: Overview01:26

Drug Discovery: Overview

7.7K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.7K
Ligand Binding Sites02:40

Ligand Binding Sites

12.8K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.8K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Differential Effects of Aging and Hearing Loss on Two Speech-Based Binaural Processes: Spectro-Temporal Integration and Interaural Cue-Based Unmasking.

Ear and hearing·2026
Same author

Guiding Caries Removal Through Biological Principles: A Narrative Review on Selective Caries Tissue Preservation.

International dental journal·2026
Same author

Sweet Round, Spicy Sharp: How Chinese Typeface Features Trick the Tongue into Tasting Five Flavors.

Behavioral sciences (Basel, Switzerland)·2026
Same author

The <i>DWARF27</i> Gene from Wintersweet (<i>Chimonanthus praecox</i>) Encodes an All-Trans/9-cis-β-Carotene Isomerase, Which Regulates Shoot Branching in <i>Arabidopsis</i>.

Plants (Basel, Switzerland)·2026
Same author

G protein-coupled receptor 87 promotes lung adenocarcinoma progression and metastasis via a histone lactylation-driven glycolytic feed-forward circuit.

Free radical biology & medicine·2026
Same author

Aging-related reconfiguration of auditory working-memory control under converging phonological and executive demands: EEG signatures and speech-in-noise performance.

Hearing research·2026

相关实验视频

Updated: Jun 15, 2025

Curation of Computational Chemical Libraries Demonstrated with Alpha-Amino Acids
08:21

Curation of Computational Chemical Libraries Demonstrated with Alpha-Amino Acids

Published on: April 13, 2022

2.6K

Rag2Mol:基于提取增强生成的基于结构的药物设计.

Peidong Zhang1,2, Xingang Peng3,4, Rong Han1,2

  • 1Department of Computer Science and Technology, Tsinghua University, Haidian District, Beijing 100084, China.

Briefings in bioinformatics
|June 12, 2025
PubMed
概括
此摘要是机器生成的。

人工智能 (AI) 通过设计适合3D口袋的分子来加速药物发现. 新的提取增强生成方法,Rag2Mol-G和Rag2Mol-R,产生优越的药物候选者,包括对于具有挑战性的目标,如PTPN2.

关键词:
发现药物的发现.提取-增强生成的回收基于结构的药物设计.

更多相关视频

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.6K
NMR-Based Fragment Screening in a Minimum Sample but Maximum Automation Mode
09:19

NMR-Based Fragment Screening in a Minimum Sample but Maximum Automation Mode

Published on: June 4, 2021

3.2K

相关实验视频

Last Updated: Jun 15, 2025

Curation of Computational Chemical Libraries Demonstrated with Alpha-Amino Acids
08:21

Curation of Computational Chemical Libraries Demonstrated with Alpha-Amino Acids

Published on: April 13, 2022

2.6K
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.6K
NMR-Based Fragment Screening in a Minimum Sample but Maximum Automation Mode
09:19

NMR-Based Fragment Screening in a Minimum Sample but Maximum Automation Mode

Published on: June 4, 2021

3.2K

科学领域:

  • 计算化学的计算化学
  • 药用化学 医学化学
  • 人工智能的人工智能

背景情况:

  • 药物发现在识别具有最佳性质的化合物方面面临挑战.
  • 基于结构的药物设计 (SBDD) 是有希望的,但受到数据偏差和缺乏合成可访问性的限制.
  • 人工智能提供了进步,但当前的SBDD模型往往与实际的药物发现脱节.

研究的目的:

  • 开发新的人工智能驱动的方法来设计适合特定3D蛋白质口袋的小分子.
  • 解决现有SBDD模型的局限性,包括数据偏差和合成可访问性.
  • 为具有挑战性的治疗目标确定强效药物候选者.

主要方法:

  • 探索两个提取增强生成方法:Rag2Mol-G和Rag2Mol-R.
  • Rag2Mol-G:生成分子,并在数据库中搜索可购买的类似化合物.
  • Rag2Mol-R:通过从现有分子数据库中创建新的分子来生成分子,这些分子适合3D口袋.

主要成果:

  • Rag2Mol 方法始终产生具有优异结合亲和度和药物相似度的候选药物.
  • Rag2Mol-R显示了比先进的虚拟选模型更广泛的化学景观覆盖范围和更精确的准.
  • 这两种工作流程都成功地确定了蛋白质氨酸酸酶PTPN2的有希望的抑制剂,这是以前无法使用的目标.

结论:

  • 开发的Rag2Mol框架代表了人工智能驱动的SBDD的重大进步.
  • 这些方法提供了一个高度可扩展的平台,用于整合各种SBDD方法.
  • 这项工作推动了具有改进药物样性质和治疗潜力的小分子的设计.